Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7803)
All Articles published online
|
Publishing Process of This Article
|
Jul 6, 2019 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo SH, Chu JG, Huang H, Yao KC. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases 2019; 7(13): 1599-1610 [PMID: 31367619 DOI: 10.12998/wjcc.v7.i13.1599] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v7/i13/1599.htm |
| Number | Citing Articles |
| 1 |
Sofia El Hajji, Stéphanie Lacotte, Beat Moeckli, François Cauchy, Philippe Compagnon, Christian Toso. Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma. Transplant International 2024; 37 doi: 10.3389/ti.2024.12781
|
| 2 |
Ling Li, Abdala Mkangala, Zhiqi Geng, Wenliang Fan, Yanqiao Ren, Zhongmin Wang, Chuansheng Zheng, Shuping Xiao. Morphine prophylaxis alleviates pain in transjugular intrahepatic portosystemic shunt procedure: A randomized clinical trial. Technology and Health Care 2023; 31(4): 1293 doi: 10.3233/THC-220572
|
| 3 |
Hélène Larrue, Manon Allaire, Delphine Weil‐Verhoeven, Sandrine Barge, Dominique Thabut, Audrey Payance, Lucile Moga, Caroline Jézéquel, Florent Artru, Isabelle Archambeaud, Laure Elkrief, Frédéric Oberti, Charles Roux, Wim Laleman, Marika Rudler, Sébastien Dharancy, Nolwenn Laborde, Anne Minello, Thomas Mouillot, Elvire Desjonquères, Line Caroll Ntandja Wandji, Marc Bourlière, Nathalie Ganne‐Carrié, Christophe Bureau. French guidelines on TIPS: Indications and modalities. Liver International 2024; 44(9): 2125 doi: 10.1111/liv.15976
|
| 4 |
俊池 李. Efficacy and Safety of TACE Combined with TIPS in the Treatment of Hepatocellular Carcinoma Complicated with Portal Hypertension: A Meta-Analysis. Advances in Clinical Medicine 2024; 14(02): 3840 doi: 10.12677/ACM.2024.142535
|
| 5 |
Suprabhat Giri, Ankita Singh, Swati Das, Kateryna Strubchevska, Taraprasad Tripathy, Ranjan Kumar Patel, Marko Kozyk, Akash Roy. Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma—A systematic review and meta-analysis. Indian Journal of Gastroenterology 2024; 43(6): 1121 doi: 10.1007/s12664-024-01646-7
|
| 6 |
Z.-X. Chen, Z.-K. Qiu, G.-B. Wang, G.-S. Wang, W.-W. Jiang, F. Gao. Safety and effectiveness of transjugular intrahepatic portosystemic shunt in hepatocellular carcinoma patients with portal hypertension: a systematic review and meta-analysis. Clinical Radiology 2023; 78(3): 209 doi: 10.1016/j.crad.2022.09.126
|
| 7 |
Hong Dong, Cunjing Zhang, Zheng Li, Haiyan Yang, Yongzheng Wang, Jibing Liu, Bin Liu, Shuzhi Mao. Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma. Journal of Cancer Research and Therapeutics 2021; 17(3): 784 doi: 10.4103/jcrt.jcrt_467_21
|
| 8 |
Blanca Norero, Jaume Bosch, Annalisa Berzigotti, Susana G. Rodrigues. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review. United European Gastroenterology Journal 2023; 11(8): 733 doi: 10.1002/ueg2.12454
|
| 9 |
Andrea Peloso, Stéphanie Lacotte, Quentin Gex, Florence Slits, Beat Moeckli, Graziano Oldani, Matthieu Tihy, Aurélie Hautefort, Brenda Kwak, Laura Rubbia-Brandt, Christian Toso, Matias A. Avila. Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models. PLOS ONE 2023; 18(12): e0296265 doi: 10.1371/journal.pone.0296265
|
| 10 |
Guo Wei, Yong Zhao, Shifeng Feng, Jingsheng Yuan, Gang Xu, Tao Lv, Jian Yang, Lingxiang Kong, Jiayin Yang. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12322-6
|
| 11 |
Anna Fichtl, Thomas Seufferlein, Eugen Zizer. Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03047-0
|
| 12 |
Huzheng Yan, Guobao Wang, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang, Fei Gao. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Translational Oncology 2020; 13(12): 100864 doi: 10.1016/j.tranon.2020.100864
|
| 13 |
Huzheng Yan, Zhenkang Qiu, Zhanwang Xiang, Kai Feng, Mingsheng Huang, Fei Gao. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging 2022; 22(1) doi: 10.1186/s40644-022-00451-9
|
| 14 |
Daniele Balducci, Michele Montori, Federico De Blasio, Alessandro Di Bucchianico, Maria Eva Argenziano, Gianluca Svegliati Baroni, Emidio Scarpellini. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma. Medicina 2023; 59(6): 1150 doi: 10.3390/medicina59061150
|
| 15 |
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdominal Radiology 2021; 46(11): 5417 doi: 10.1007/s00261-021-03214-5
|
| 16 |
Zhi-Qiang Wu, Fan Wang, Feng-Pin Wang, Hong-Jie Cai, Song Chen, Jian-Yong Yang, Wen-Bo Guo. Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus. World Journal of Gastrointestinal Surgery 2024; 16(9): 2778-2786 doi: 10.4240/wjgs.v16.i9.2778
|